Global Livestock Vaccine
Market Report
2024
Livestock vaccine market will be USD 5514.2 million in 2024 and expand at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Livestock Vaccine Market Report 2024.
According to Cognitive Market Research, the global Livestock vaccine market will be USD 5514.2 million in 2024 and expand at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Livestock Vaccine Market Sales Revenue 2024 | $ 5514.2 Million |
Global Livestock Vaccine Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.5% |
Europe Livestock Vaccine Sales Revenue 2024 | $ 1654.26 Million |
North America Livestock Vaccine Sales Revenue 2024 | $ 2205.68 Million |
North America Livestock Vaccine Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 2.7% |
South America Livestock Vaccine Sales Revenue 2024 | $ 275.71 Million |
South America Livestock Vaccine Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.9% |
Middle East and Africa Livestock Vaccine Sales Revenue 2024 | $ 110.28 Million |
Middle East and Africa Livestock Vaccine Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.2% |
Asia Pacific Livestock Vaccine Sales Revenue 2024 | $ 1268.27 Million |
Asia Pacific Livestock Vaccine Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.5% |
Market Split by Vaccine Type |
|
Market Split by Technology |
|
Market Split by Route of Administration |
|
Market Split by End-user |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Livestock Vaccine industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Livestock Vaccine Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The market's industry trends are analyzed in the latest research study. Industry trends, pricing analysis, patent analysis, conference and webinar materials, important stakeholders, and market purchasing behavior are all included in the latest research study. The increasing number of companion animals and initiatives from various government agencies and animal associations are the main causes of this market's growth. Globally, there has been a notable increase in the number of companion animals and their adoption rate. Numerous studies have shown that keeping a companion animal is linked to enhanced psychological stability, lowered anxiety, normalized blood pressure, fewer cardiac arrhythmias, and overall better health. The growing number of pets is anticipated to fuel demand for pet care goods and services.
The demand for livestock goods like meat and dairy products is rising globally, which is good news for the livestock industry. This tendency has been seen in industrialized nations in North America and Europe.
The demand for animal food products, such as eggs, milk and dairy, pigs, poultry, cattle, veal, buffalo, mutton, lamb, and goat meat, is rising worldwide. Globally, 17% of calories and 33% of protein are derived from livestock products; however, this percentage differs between industrialized and developing nations. The strong demand for food products derived from animals is likely to drive significant expansion in the livestock industry overall.
According to a survey conducted by the Food and Agriculture Organization of the United Nations (FAO) to map the supply and demand for food sourced from animals, Asian nations are expected to experience the greatest growth in demand for livestock products like beef, milk, mutton, pork, and poultry products (eggs and chicken). As per the reports from the Guardian and the Bureau of Investigative Journalism, there were 1,786 industrial-sized pig and poultry facilities in the UK in 2020, an increase of 7% from 1,669 in 2017.
Veterinary immunizations protect the health of the animals and boost overall output in livestock farming. More productive animal production and better access to high-quality protein are needed to feed the world's expanding population. According to an FAO High-Level Expert Forum, to feed the projected 9.1 billion people on the planet by 2050, there would need to be a 70% increase in overall food output. Vaccinations that safeguard animal health and boost supply will be crucial in achieving this objective.
Additionally, because of growing concerns about antibiotic resistance linked to the introduction of antibiotics in veterinary and human medicine, as well as their ability to eradicate the thinning of organisms causing foodborne illness in humans, they lessen the need for antimicrobials to treat infections in food-producing and companion animals, which will boost the market growth in the forecast period.
The main reasons behind the widespread acceptance of ruminants, particularly cattle vaccinations, worldwide are the rising number of cattle disease outbreaks and the constantly growing livestock population. Animals are an essential source of food, milk, meat, protein, and other goods used in industry, like wool and leather. The three most commonly used animal vaccines are those against rabies, equine influenza virus, and foot and mouth illnesses. These vaccines work by imitating naturally acquired immunity to stop the spread of infectious pathogens.
Effective storage is one of the main challenges that makers of veterinary vaccines confront along the supply chain. Deep freezing is the primary method of low-temperature storage for vaccines, and it is important to keep the temperature low during storage and transit until the vaccine is given to animals. A minor mistake in vaccine storage can result in thousands of dollars in wasted vaccine and costs associated with revaccination programs.
Approximately 80% of the cost of vaccines is due to cold storage. Manufacturers and distributors of vaccines frequently employ refrigerators, thermometers, and cold chain monitors, among other vaccine storage equipment and monitoring systems, for efficient storage. The price of a single vaccine storage refrigerator typically ranges from USD 2,000 to $50,000, depending on the unit's size and the quantity of vaccinations being kept. Vacuum storage equipment must be properly chosen, maintained (including professionally repaired), and continuously monitored to maintain the necessary temperature. As such, this method costs vaccine makers a lot of money.
Incidents involving COVID-19-infected farmed minks were documented in late 2020 in several nations, including Denmark and the United States. These occurrences have consequently raised demand for the COVID-19 animal vaccine. Consequently, industry players are working together to create veterinary vaccinations that protect against COVID-19. For example, to support the preservation of the health and welfare of Zoo animals, Zoetis is now giving more than 11,000 doses of its investigational COVID-19 vaccine. On the other hand, in April 2021, Russia registered Carnivac-Cov, the world's first Covid-19 vaccination for animals. Because of this, the growing frequency of COVID-19 infections in both domestic and wild animals would boost the industry's growth by increasing the acceptability of animal vaccinations to ensure preventive healthcare for animals.
We have various report editions of Livestock Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Numerous small and major animal vaccine makers are in the industry, characterized by intense competition. The main factors influencing competitiveness are the quick uptake of veterinary preventative injections in conjunction with government-funded bulk vaccination purchases. Furthermore, prominent businesses often resort to different techniques, including partnerships, mergers and acquisitions, and new product releases, to maintain market share and broaden their product range.
In February 2021, Ceva collaborated with the French National Research Institute for Agriculture, Food, and Environment (INRAE) for research and development aimed at preventing infectious diseases of animal origin and enhancing animal health.
(Source: https://www.ceva.com/press-release/research-and-innovation-in-animal-health-a-strengthened-partnership-between-inrae-and-ceva-sante-animale/)
In January 2021, The Poulvac Procerta HVT-IBD vaccine was introduced by Zoetis to protect chickens from Infectious Bursal Disease (IBD). This expanded the range of recombinant vector vaccines offered by the company.
Top Companies Market Share in Livestock Vaccine Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Global Livestock Vaccine Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Livestock Vaccine Industry growth. Livestock Vaccine market has been segmented with the help of its Vaccine Type, Technology Route of Administration, and others. Livestock Vaccine market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
According to Cognitive Market Research, the bovine vaccine held the major market share over the forecast period. The increasing number of cows worldwide is believed to drive up demand for bovine vaccinations, accelerating segmental expansion throughout the projection period and accounting for the segment share.
Poultry vaccine is the fastest-growing category over the forecast period. The increasing number of sick chickens in the population and the increasing use of poultry vaccinations by medical facilities to stop outbreaks of poultry-related diseases are the reasons for the segment's growth. These elements are anticipated to accelerate segmental growth during the projection.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Livestock Vaccine Industry. Request a Free Sample PDF!
According to Cognitive Market Research, live attenuated vaccines hold a prominent market share. The growing number of farm animal diseases and the strong demand for this commodity, particularly in developing nations, are to blame for the segment's size. Additionally, live attenuated vaccinations successfully induce cell-mediated immune responses and can fortify and sustain an animal's immune system. Modern live attenuated vaccines are developed and researched to do this. Among these R&D projects is the creation of swine protein subunit vaccines. The injection of these vaccinations is done intramuscularly. These elements play a major role in the increased demand for and preference for this vaccine.
Recombinant vaccine is the fastest-growing category over the forecast period. The increased introduction and development of cutting-edge recombinant vaccines by industry players for treating the livestock population is the cause of this segmental expansion. For example, Boehringer Ingelheim International GmbH's U.S. animal health division unveiled VAXXITEK HVT+IBD+ILT, a recombinant vaccine, in October 2020 to protect chickens against three diseases.
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Livestock Vaccine market report 2024 Edition by contacting our team.
According to Cognitive Market Research, parenterals hold a prominent market share. The parenteral mode of administration offers several advantages, including rapid onset of immunity, adaptability, established practice, and reliable immune response induction. These advantages are anticipated to expand the segment over the forecast period.
Oral is the fastest-growing category over the forecast period. The surge in various R&D projects and the rise in clinical trials involving novel and advanced vaccinations are the causes of the segmental expansion. Additionally, during the projected period, it is anticipated that the increasing introduction of vaccines via this mode of administration will support segmental expansion.
According to Cognitive Market Research, veterinary clinics hold a prominent market share. Clinicians ascribe the larger sector share to the increasing use of cattle vaccinations. In addition, an increasing number of veterinarians and the high volume of animals seeking care in clinics are expected to support segmental expansion over the forecast period.
Veterinary hospitals are the fastest-growing category over the forecast period. When post-vaccination care is needed, animal owners are increasingly choosing veterinary hospitals, which is why the market is rising. In addition, these institutions have state-of-the-art care facilities to prevent problems following immunization. The advantages above are anticipated to drive segmental expansion over the projection period.
According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. This significant portion can be linked to the high frequency of livestock and zoonotic illnesses that cause widespread animal fatalities. Furthermore, a significant number of well-known pharmaceutical companies are anticipated to contribute to the market's growth as they continuously work to expand their geographic reach and commercialize their vaccines on a broad scale. The growing pet population in the United States and the increasing prevalence of canine diseases are also important factors driving the regional market's growth. Vaccination against these diseases is becoming more widely used.
The Asia Pacific region is witnessing an increase in sales. Some key elements predicted to accelerate market expansion in the region are the anticipated increase in cattle and government initiatives, particularly in developing nations. According to the National Dairy Development Board, India's cow population increased from 190.9 million in 2012 to 192.5 million in 2019. Because of this, there is a need for vaccines in a nation with such a big cow population. The market is driven by significant R&D spending by numerous large competitors and increased efforts to commercialize veterinary vaccinations and inoculations at reasonable costs.
The current report Scope analyzes Livestock Vaccine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Cognitive Market Research shows a market value of USD 5514.2 million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 3.0% from 2024 to 2031. Europe accounted for over 30% of the global market size of USD 1654.26 million. Animal protein is produced and consumed in large quantities throughout the European Union, where meat consumption is predicted to rise further in the years to come. To meet this requirement, a healthy population of animals is required. European regulations and customer preferences prioritize animal welfare and proactive actions to control animal diseases. To do this, vaccination is essential.
According to Cognitive Market Research, the global livestock vaccine market size was estimated at USD 5514.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 2205.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031. The North American livestock vaccine market is expected to grow in the coming years, driven by rising demand for meat, milk, and eggs and growing awareness of animal health and welfare. The development of new and improved vaccines and increasing government support for animal health are expected to boost the market further. As the population of North America grows, so does the demand for animal-based protein sources. This drives demand for vaccines that can help keep livestock healthy and productive. Many governments in North America have strict regulations in place to prevent the spread of animal diseases. These regulations often require the use of vaccines for certain livestock populations.
According to Cognitive Market Research, the global Livestock vaccines market size was estimated at USD 5514.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 275.71 million in 2024 and will grow at compound annual growth rate (CAGR) of 3.9% from 2024 to 2031. Latin America is home to some of the world's largest cattle, pigs, and poultry herds. Brazil, for example, is the world's largest beef exporter and the third-largest poultry producer. Farmers are becoming increasingly aware of the importance of vaccinating their animals to prevent diseases that can lead to significant economic losses. Many governments in Latin America provide financial and technical support for vaccination programs, helping boost vaccine demand.
According to Cognitive Market Research, the global livestock vaccine market size was estimated at USD 5514.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 110.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031. The growing demand for meat, milk, and other animal products will likely fuel a large increase in the number of livestock in the MEA region in the upcoming years. More vaccinations are becoming necessary as a result of shielding animals from illness. Farmers in the MEA region are prepared to spend money on vaccines to protect their animals because they recognize how important animal health is. The main drivers are government campaigns, educational initiatives, disease outbreaks like peste des petits ruminants, and foot-and-mouth disease.
According to Cognitive Market Research, the global livestock vaccine market size was estimated at USD 5514.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1268.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031. The Asia Pacific region is home to the world's largest livestock population, with China and India leading the way. This large and growing population is driving demand for vaccines to prevent and control. Farmers are becoming increasingly aware of the importance of animal health for productivity and profitability. This is leading to increased adoption of vaccines, as well as other animal health products and services.
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
I am a dedicated and detail-oriented research analyst, committed to unraveling the stories hidden within data. With a solid foundation in market research & analysis, I thrive in the dynamic realm of research, where every dataset presents an opportunity for discovery. My passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.
I am committed to continuous professional development, regularly participating in workshops, attending conferences, and staying attuned to emerging trends in research methodologies to maintain the highest standards in my work. I played a vital role in conducting market research and competitive analysis. I have a proven track record of synthesizing diverse datasets, employing statistical models, and presenting comprehensive insights. My collaborative approach with cross-functional teams facilitated effective communication of findings, fostering a culture of data-driven decision-making within the organization.
Table of Content differs accordign to the user License selction. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section's Or chapter's from the report. Specific section's of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Vaccine Type | Bovine Vaccine, Poultry Vaccine, Porcine Vaccine, Others |
Technology | Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, Others |
Route of Administration | Oral, Parenteral, Others |
End-user | Veterinary Hospitals, Veterinary Clinics, Others |
List of Competitors | AniCon Labor GmbH , Animal Science Products Inc. , Biovac , Boehringer Ingelheim International GmbH , ADL BIONATUR SOLUTIONS S.A. , Ceva Sante Animale , Elanco , Merck & Co., Phibro Animal Health Corporation , Zoetis Inc |
This chapter will help you gain GLOBAL Market Analysis of Livestock Vaccine. Further deep in this chapter, you will be able to review Global Livestock Vaccine Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Chapter 2 North America Market Analysis
Executive Summary North America Market (2019 vs 2024 vs 2031)
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
Qualitative Analysis for the North America Market: North America Livestock Vaccine Market Trends North America Livestock Vaccine Technological Road Map North America Livestock Vaccine Market Drivers North America Livestock Vaccine Market Restraints North America Livestock Vaccine Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
Chapter 3 Europe Market Analysis
Chapter 4 Asia-Pacific Market Analysis
Chapter 5 South America Market Analysis
Chapter 6 Middle East and Africa Market Analysis
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Vaccine Type Analysis 2019 -2031, will provide market size split by Vaccine Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Vaccine Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Technology Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Route of Administration Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by End-user Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Livestock Vaccine market
Chapter 14 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Bovine Vaccine have a significant impact on Livestock Vaccine market? |
What are the key factors affecting the Bovine Vaccine and Poultry Vaccine of Livestock Vaccine Market? |
What is the CAGR/Growth Rate of Live Attenuated Vaccine during the forecast period? |
By type, which segment accounted for largest share of the global Livestock Vaccine Market? |
Which region is expected to dominate the global Livestock Vaccine Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Livestock Vaccine Market
Request Sample